Indeed, the long-term administration of PDE inhibitors to patients with heart failure leads to an increase in mortality that correlates with an increase in ventricular arrhythmias and sudden cardiac death (Packer et al., 1991; Amsallem et al., 2005). The gene discussed is ALDH7A1; the disease is heart failure.